Senators tell drug company executives pricing is 'morally repugnant'

WASHINGTON/NEW YORK: U.S. Senators called drug pricing practices"morally repugnant" and told drug company executives they do not want to hear them blame others for the high prices, taking an aggressive stance at the start of a Senate hearing on the rising costs of prescription medicines.

Congress has already held several hearings on rising prescription drug prices in both the Democrat-controlled House of Representatives and the Republican-led Senate, but Tuesday's hearing is the first time drug company executives, most of them CEOs, will face lawmakers in more than two years. Pharmaceutical companies have blamed high research and development costs for their prices, as well as discounts, or rebates, they must provide to pharmacy benefits managers and insurers to ensure patient access to their medicines. HHS has proposed a rule to eliminate rebates in Medicare and Medicaid, the government health insurance programs.

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين

Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.

Drug company executives to testify before SenateSeven drug company executives will testify about rising prescription drug prices before a powerful U.S. Senate Committee on Tuesday, marking a ...
مصدر: ChannelNewsAsia - 🏆 6. / 66 اقرأ أكثر »

Singapore C-suite execs, finance staff believe business decisions were based on inaccurate data: pollA SURVEY of C-suite executives and financial professionals in Singapore has found more than seven in 10 respondents believe that their organisation has made significant business decisions based on inaccurate data. They identified this as a hidden problem, with close to half (45 per cent) stating concern over errors that they know must exist, but of which they have no visibility. Read more at The Business Times.
مصدر: BusinessTimes - 🏆 15. / 51 اقرأ أكثر »